The Mexican government is working on a regulation to regulate the exports and imports of cannabis products.
The Secretary of Health (SSA) presented a preliminary draft of the Regulation on Health Control for the Production, Research and Medicinal Use of Cannabis and its Pharmaceutical Derivatives.
In this document, presented to the National Commission for Regulatory Improvement (Conamer), it is established that for the purposes regulated in the regulation, raw materials, molecular complexes, pharmacological derivatives or medications may be imported.
Also according to the purposes regulated in the regulation, pharmacological derivatives and medicines may be exported.
Imports or exports, as the case may be, of raw material, molecular complexes, pharmacological derivatives or drugs may not be carried out, under any circumstances, by post, courier or parcel companies, or in other cases provided by the regulations of the matter that regulate customs clearance.
Exports
To obtain the certificate, in the case of exports, an application must be submitted in the official format to which the original letter of acceptance of the final importer will be attached on letterhead. It will comply with the procedures and deadlines established for such purposes.
Granted a free sale certificate of pharmacological derivatives and medicines, the interested party will give notice to the Federal Commission for the Protection against Sanitary Risks (Cofepris) of the date on which the export is intended to be carried out, so that a sanitary verifier will be appointed to record in which it appears:
- That the input corresponds to that authorized, corroborating numbers and dates of export and import permits, product name, Lot number, expiration date and quantity.
- The name of the carrier.
III. That the input was wrapped, sealed and sealed.
The above data must be entered in the control book authorized by Cofepris, in the presence of the health officer of the establishment.
The purpose of this ordinance is the regulation, control, promotion and sanitary surveillance of raw materials, molecular complexes, pharmacological derivatives and medicines for scientific, industrial and medical production purposes, according to which the Ministry of Health, through Cofepris ; the Ministry of Agriculture and Rural Development, through the National Service of Health, Safety and Agro-Food Quality and the National Service of Inspection and Certification of Seeds; the Ministry of Economy; The Secretary of Finance and Public Credit, through the Tax Administration Service, shall exercise the powers conferred by laws, regulations and other legal provisions within the scope of its competence.
